Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Syntheses and in vitro biological evaluation of S1PR1 ligands and PET studies of four F-18 labeled radiotracers in the brain of nonhuman primates

Journal Article · · Organic and Biomolecular Chemistry
DOI:https://doi.org/10.1039/c8ob02609b· OSTI ID:1611052
A series of seventeen hydroxyl-containing sphingosine 1-phosphate receptor 1 (S1PR1) ligands were designed and synthesized. Their in vitro binding potencies were determined using [32P]S1P competitive binding assays. Compounds 10a, 17a, 17b, and 24 exhibited high S1PR1 binding potencies with IC50 values ranging from 3.9 to 15.4 nM and also displayed high selectivity for S1PR1 over other S1P receptor subtypes (IC50 > 1000 nM for S1PR2–5). The most potent compounds 10a, 17a, 17b, and 24 were subsequently radiolabeled with F-18 in high yields and purities. MicroPET studies in cynomolgus macaque showed that [18F]10a, [18F]17a, and [18F]17b but not [18F]24 crossed the blood brain barrier and had high initial brain uptake. Further validation of [18F]10a, [18F]17a, and [18F]17b in preclinical models of neuroinflammation is warranted to identify a suitable PET radioligand to quantify S1PR1 expression in vivo as a metric of an inflammatory response.
Research Organization:
Washington University, St. Louis, MO (United States)
Sponsoring Organization:
USDOE; USDOE Office of Science (SC)
Grant/Contract Number:
SC0008432
OSTI ID:
1611052
Alternate ID(s):
OSTI ID: 1483021
Journal Information:
Organic and Biomolecular Chemistry, Journal Name: Organic and Biomolecular Chemistry Journal Issue: 47 Vol. 16; ISSN 1477-0520
Publisher:
Royal Society of ChemistryCopyright Statement
Country of Publication:
United States
Language:
English

References (45)

Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple Sclerosis journal October 2012
Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1‐phosphate signalling to regulate tumour metastasis journal June 2012
S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures journal November 2011
Fingolimod-A sphingosine-like molecule inhibits vesicle mobility and secretion in astrocytes journal May 2012
The Pharmacology of PEGylation: Balancing PD with PK to Generate Novel Therapeutics journal October 2008
PET Imaging Study of S1PR1 Expression in a Rat Model of Multiple Sclerosis journal March 2016
A promising carbon-11-labeled sphingosine-1-phosphate receptor 1-specific PET tracer for imaging vascular injury journal February 2016
Molecular cloning of a novel putative G protein-coupled receptor from rat aortic smooth muscle. Downregulation of the mRNA level by the cyclic AMP messenger pathway journal June 1994
An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. journal June 1990
A practical process for the preparation of [32P]S1P and binding assay for S1P receptor ligands journal August 2015
Synthesis of fluorinated analogues of sphingosine-1-phosphate antagonists as potential radiotracers for molecular imaging using positron emission tomography journal October 2014
Sphingosine-1-Phosphate Links Persistent STAT3 Activation, Chronic Intestinal Inflammation, and Development of Colitis-Associated Cancer journal January 2013
Syntheses and in vitro evaluation of new S1PR1 compounds and initial evaluation of a lead F-18 radiotracer in rodents journal April 2018
Fingolimod phosphate promotes the neuroprotective effects of microglia journal March 2013
Current drug research on PEGylation with small molecular agents journal March 2013
PET radiotracers: crossing the blood–brain barrier and surviving metabolism journal August 2009
Imaging S1P1 activation in vivo journal May 2015
Systemic distribution, subcellular localization and differential expression of sphingosine-1-phosphate receptors in benign and malignant human tissues journal October 2014
Discovery and Structure–Activity Relationship (SAR) of a Series of Ethanolamine-Based Direct-Acting Agonists of Sphingosine-1-phosphate (S1P 1 ) journal July 2016
Design, Synthesis, and In Vitro and In Vivo Evaluation of an 18 F-Labeled Sphingosine 1-Phosphate Receptor 1 (S1P 1 ) PET Tracer journal June 2016
Multidentate 18 F-Polypegylated Styrylpyridines As Imaging Agents for Aβ Plaques in Cerebral Amyloid Angiopathy (CAA) journal December 2011
Synthesis and Evaluation of Fluorinated Fingolimod (FTY720) Analogues for Sphingosine-1-Phosphate Receptor Molecular Imaging by Positron Emission Tomography journal April 2015
18 F Stilbenes and Styrylpyridines for PET Imaging of Aβ Plaques in Alzheimer’s Disease: A Miniperspective journal February 2010
Redox Behavior of Ferrocene-Containing Rotaxane:  Transposition of the Rotaxane Wheel by Redox Reaction of a Ferrocene Moiety Tethered at the End of the Axle journal May 2004
Sphingosine-1-phosphate receptor-1 (S1P1) is expressed by lymphocytes, dendritic cells, and endothelium and modulated during inflammatory bowel disease journal April 2016
Sphingolipid metabolites in inflammatory disease journal June 2014
STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors journal November 2010
Sphingosine 1-phosphate and cancer journal June 2010
Effect of pegylation on pharmaceuticals journal March 2003
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation journal December 2010
Molecular Cloning and Functional Characterization of Murine Sphingosine Kinase journal September 1998
FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system: FTY720 mode of action journal October 2009
Pegylation Improves the Pharmacokinetics and Bioavailability of Small-Molecule Drugs Hydrolyzable by Esterases: A Study of Phospho-Ibuprofen journal July 2014
Modulation of P-Glycoprotein at the Blood-Brain Barrier: Opportunities to Improve Central Nervous System Pharmacotherapy journal June 2008
Sphingosine-1-Phosphate as a Ligand for the G Protein-Coupled Receptor EDG-1 journal March 1998
Sphingosine-1-Phosphate Induces an Antiinflammatory Phenotype in Macrophages journal April 2008
Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy journal April 2015
PET Study of Sphingosine-1-Phosphate Receptor 1 Expression in Response to Vascular Inflammation in a Rat Model of Carotid Injury journal January 2017
Fingolimod modulates microglial activation to augment markers of remyelination journal January 2011
An update on the biology of sphingosine 1-phosphate receptors journal January 2014
Defining the clinical course of multiple sclerosis: Results of an international survey journal April 1996
Relevance and potential of sphingosine-1-phosphate in vascular inflammatory disease journal November 2008
Medicinal chemical properties of successful central nervous system drugs journal October 2005
Fingolimod (FTY720) Enhances Remyelination Following Demyelination of Organotypic Cerebellar Slices journal June 2010
High Expression of Sphingosine 1-Phosphate Receptors, S1P1 and S1P3, Sphingosine Kinase 1, and Extracellular Signal-Regulated Kinase-1/2 Is Associated with Development of Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Patients journal November 2010

Cited By (1)

Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers journal April 2019

Similar Records

PET Imaging Study of S1PR1 Expression in a Rat Model of Multiple Sclerosis
Journal Article · Sun Mar 13 20:00:00 EDT 2016 · Molecular Imaging and Biology · OSTI ID:1463267

Design, Synthesis, and In Vitro and In Vivo Evaluation of an 18 F-Labeled Sphingosine 1-Phosphate Receptor 1 (S1P1) PET Tracer
Journal Article · Wed Jun 08 20:00:00 EDT 2016 · Journal of Medicinal Chemistry · OSTI ID:1466768